Effect of Tetrabenazine on Tics & Sleep of Gilles de la Tourette's Syndrome
Neurol 34:688-692, Jankovic,J.,et al, 1984
Treatment of Tourette's Syndrome with R022-1913, A D-2-Receptor Antagonist
NEJM 311:989, Uhr,S.B.,et al, 1984
Senile-Onset Vocal & Motor Tics
Arch Neurol 40:825-826, Sutula,T.,et al, 1983
Long Latency Between the Onset of Motor & Vocal Tics in Tourette's Syndrome
Ann Neurol 14:693-694, Lang,A.E.,et al, 1983
Oligoclonal IgG Bands in Cerebrospinal Fluid in Various Neurological Diseases
Ann Neurol 13:434-439, Chu,A.B.,et al, 1983
The Electroencephalogram in Tourette Syndrome
Ann Neurol 11:382-385, Bergen,D.,et al, 1982
Stimulant Medications Precipitate Tourette's Syndrome
JAMA 247:1168-1169, Lowe,T.L.,et al, 1982
Misdiagnosis of Stroke
Lancet 1:328-331, Norris,J.W.&Hachinski,V.C., 1982
Tic Disorders
JAMA 245:1583-1585, Shapiro,E.,et al, 1981
Physostigmine In Gilles De La Tourettes Syndrome
NEJM 302:298, Stahl,S.M.,et al, 1980
Gilles de la Tourette Syndrome & Compressive Neuropathies, Letter
Ann Neurol 8:453, Goetz,C.G.,et al, 1980
Haloperidol-Induced Tardive Dyskinesia in a Child With Gilles de la Tourette's Disease
Arch Neurol 37:780, Mizrahi,E.M.,et al, 1980
Familial Tourette Syndrome
Ann Neurol 5:104, Guggenheim,M.A., 1979
Improvement in Gilles de la Tourette Syndrome after Corticosteroid Therapy
Ann Neurol 4:387, Kondo,K.,et al, 1978
Tics & Tourette's:A Continuum of Symptoms
Ann Neurol 4:145-148, Golden,G.S., 1978
Gilles de la Tourette's syndrome:Clinical, Genetic, Psychologic, & Biochemical Aspects in 21 Selected Families
Neurol 27:115, Eldridge,R.,et al, 1977
The Effect of Central Nervous System Stimulants on Tourette Syndrome
Ann Neurol 2:69, Golden,G.S., 1977
Purine Phosphoribosyltransferase in Gilles de la Tourette Syndrome
NEJM 296:210, VanWoert,M.H.,et al, 1977
Clinical Diagnosis of the Dyskinesias
Med Clin of North Am 56:1321, Duvoisin,R., 1972
MR Mismatch Is Useful for Patient Selection for Thrombolysis: No
Stroke 40:2908-2909,2910, Sch�bitz,W.R.,
Disseminated Brain Infarcts Associated with Uterine Myoma
Stroke 57:e61-e62, Elbischger,J.,et al, 2026
Clinicopathologic Conference, Disseminated Infection with Hypervirulent Klebsiella Pneumoniae
NEJM 394:282-294, Case 202026, 2026
Increased Prevalence of Nitrous Oxide-Induced Subacute Combined Degeneration of the Spinal Cord: Clinical and Imaging Findings
AJNR 47:513-520, Bruen,R.,et al, 2026
Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After IschemicStroke, The OPTION Randomized Clinical Trial
JAMA doi:10.1001/JAMA.2026.0210, Ma,G.,et al, 2026
Mucormycosis
NEJM 394:684-698, Kontoyiannia,D.P. & Walsh, T.J., 2026
Secondary Prevention after Ischemic Stroke
NEJM 394:784-792, Frie,K.L.,et al, 2026
Neurosyphilis with Abnormal in the Bilateral Pons and Multifocal Cranial Nerve Enhancement
Ann Neurol 99:283-284, Zhang,Y.,et al, 2026
CT Perfusion Abnormality in Hypoglycemic Focal Neurological Deficits
Stroke 57:e6-e7, Mikito,S.,et al, 2026
Reversible Leukoencephalopathy and Parkinsonism Due to CNS Involvement in Cryoglobulinemia
Neurol 106:e214622, German,A.,et al, 2026
Stroke Mechanism and Severity after Left Atrial Appendage Occlusion, Insights from the LAAOS III Randomized Clinical Trial
JAMA Neurol 83:76-82, Katsanos,A.H.,et al, 2026
Intravenous Thrombolysis Use in the Late Time Window Before Interhospital Transfer for Thrombectomy
JAMA Neurol 83:60-67, Seners,P.,et al, 2026
Unilateral Primary Angiitis of the Central Nervous System: A Rare and Under-Recognized Entity
AJNR 47:589-595, Rai,P.,et al, 2026
Niemann-Pick Type C Disease
www.UpToDate.com, Nov, Schiffmann, R., 2026
Using Susceptibility-Based Imaging in Highly Active Late-Onset Multiple Sclerosis
Neurol 106:e214794, Sosa,S.M.,et al, 2026
Clinical Manifestations of Primary CNS T-Cell Lymphoma, Retrospective Study of Histopathologic, Molecular, and Neuroimaging Fetures
Neurol 106:e24744, Muller,K.J.,et al, 2026
Patterns and Factors Associated with Cerebral Infarction on MRi in Tuberculous Meningitis: Secondary Anlysis of the ACT-TBM Trial
Stroke 57:856-864, Chandu,M.,et al, 2026
Frequency of AQP4 and MOG Antibodies in Patients with Optic Neuritis Fulfilling Minimal New Multiple Sclerosis MRI Criteria
Neurol 106:e214753, Deschamps,R.,et al, 2026
Using Susceptibility-Based Imaging in highly ctive Late-Onset Multiple Sclerosis
Neurol 106:e214794, Sosa,S.M.,et al, 2026
Asundexian for Secondary Stroke Prevention
NEJM 394:1467-1479, 1540, Sharm,M.,et al, 2026
Endovascular Therapy for Medium-Vessel Occlusion Stroke - Narrowing the Target Population
NEJM 394:1955-1957,1894, Ospel,J.M. & Hill, M.D., 2026
A 28-Year-Old Man with Seizures and Thalamic Lesions
Neurol 106:e218065, Santos-Rojo,A.B.,et al, 2026
A 35-Year-Old Patient with Rapidly Progressive Ascending Weakness Leading to Loss of Brainstem Reflexes
Neurol 106:e218059, Lyons,H.J.,et al, 2026
A Woman with Parkinson Disease, Dyskinesia, Rhadomyolysis, Subcutaneous Emphysema, and Pneumomediastinum
Neurol 106:e218064, Iqbal,M.M.,et al, 2026
Deep Venous Dural Arteriovenous Fistula Mimicking Progressive Dementia
Stroke 57:e180-181, Langlois-Therien,T.,et al, 2026
Dental Flossing May Lower the Risk for Incident Ischemic Stroke, Cardioembolic Stroke Subtype, and Atrial Fibrillation
Stroke 57:1275-1282, Sen,S.,et al, 2026
Syphilitic Aortitis Presenting as Aortic Arch Thrombus and Acute Ischemic Stroke
Neurol 106:e214868, Ferro,J.,et al, 2026
Cerebral Amyloid Angiopathy
NEJM 394:1836-1845, Greenberg,S.M., 2026
Safety and Outcomes of Dibigatran Reversal with Idarucizumab Before IV Thrombolysis in Patients with Acute Ischemic Stroke
Neurol 106:e218012, Saflund,M.,et al, 2026
Cerebral Syphilitic Vasculitis Presenting with Recurrent Stroke
Stroke 57:e197-e198, Yilmaz,E.,et al, 2026
Niemann-Pick Disease Type C
Gene Reviews www.genereview.org, Bremova-Ertl,T. & Patterson, M., 2025